Insulet Corp (PODD) stock
PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3045% below fair value
$152.48+3.19 (+2.14%)
Close on Nov 13, 2026Market cap $10.58BP/E 24.8Yield –
Insulet operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Insulet's operating income for the twelve months ending Sep 30, 2026 was $587.90M, up 34.6% year over year. For fiscal 2025 it was $473.80M, up 53.4% from the year before. The highest annual figure on record is $473.80M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $473.80M | +53.4% |
| FY2024 | Dec 31, 2024 | $308.90M | +40.3% |
| FY2023 | Dec 31, 2023 | $220.10M | +485.4% |
| FY2022 | Dec 31, 2022 | $37.60M | -70.2% |
| FY2021 | Dec 31, 2021 | $126.00M | +144.7% |
| FY2020 | Dec 31, 2020 | $51.50M | +3.0% |
| FY2019 | Dec 31, 2019 | $50.00M | +82.5% |
| FY2018 | Dec 31, 2018 | $27.40M | – |
| FY2017 | Dec 31, 2017 | -$7.40M | – |
| FY2016 | Dec 31, 2016 | -$10.70M | – |
| FY2015 | Dec 31, 2015 | -$48.74M | – |
| FY2014 | Dec 31, 2014 | -$8.87M | – |
| FY2013 | Dec 31, 2013 | -$29.14M | – |
| FY2012 | Dec 31, 2012 | -$35.97M | – |
| FY2011 | Dec 31, 2011 | -$42.47M | – |
| FY2010 | Dec 31, 2010 | -$38.63M | – |
| FY2009 | Dec 31, 2009 | -$59.36M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $189.80M | +61.3% |
| Q2 FY2026 | Jun 30, 2026 | $129.70M | +7.1% |
| Q1 FY2026 | Mar 31, 2026 | $122.10M | +37.5% |
| Q4 FY2025 | Dec 31, 2025 | $146.30M | +33.9% |
| Q3 FY2025 | Sep 30, 2025 | $117.70M | +33.6% |
| Q2 FY2025 | Jun 30, 2025 | $121.10M | +122.2% |
| Q1 FY2025 | Mar 31, 2025 | $88.80M | +56.1% |
| Q4 FY2024 | Dec 31, 2024 | $109.30M | +2.6% |
| Q3 FY2024 | Sep 30, 2024 | $88.10M | +60.8% |
| Q2 FY2024 | Jun 30, 2024 | $54.50M | +75.2% |
| Q1 FY2024 | Mar 31, 2024 | $56.90M | +105.4% |
| Q4 FY2023 | Dec 31, 2023 | $106.50M | +353.2% |
| Q3 FY2023 | Sep 30, 2023 | $54.80M | +1789.7% |
| Q2 FY2023 | Jun 30, 2023 | $31.10M | – |
| Q1 FY2023 | Mar 31, 2023 | $27.70M | -26.9% |
| Q4 FY2022 | Dec 31, 2022 | $23.50M | -52.7% |
| Q3 FY2022 | Sep 30, 2022 | $2.90M | -91.4% |
| Q2 FY2022 | Jun 30, 2022 | -$26.70M | -201.5% |
| Q1 FY2022 | Mar 31, 2022 | $37.90M | +132.5% |
| Q4 FY2021 | Dec 31, 2021 | $49.70M | – |
| Q3 FY2021 | Sep 30, 2021 | $33.70M | +41.6% |
| Q2 FY2021 | Jun 30, 2021 | $26.30M | -4.4% |
| Q1 FY2021 | Mar 31, 2021 | $16.30M | +117.3% |
| Q4 FY2020 | Dec 31, 2020 | -$7.30M | -140.3% |
| Q3 FY2020 | Sep 30, 2020 | $23.80M | +40.0% |
| Q2 FY2020 | Jun 30, 2020 | $27.50M | +261.8% |
| Q1 FY2020 | Mar 31, 2020 | $7.50M | +2.7% |
| Q4 FY2019 | Dec 31, 2019 | $18.10M | +11.5% |
| Q3 FY2019 | Sep 30, 2019 | $17.00M | +147.6% |
| Q2 FY2019 | Jun 30, 2019 | $7.60M | +75.7% |
| Q1 FY2019 | Mar 31, 2019 | $7.30M | – |
| Q4 FY2018 | Dec 31, 2018 | $16.23M | – |
| Q3 FY2018 | Sep 30, 2018 | $6.87M | +235.4% |
| Q2 FY2018 | Jun 30, 2018 | $4.33M | – |
| Q1 FY2018 | Mar 31, 2018 | $0 | – |
| Q4 FY2017 | Dec 31, 2017 | -$768.00K | – |
| Q3 FY2017 | Sep 30, 2017 | $2.05M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.36M | – |
| Q1 FY2017 | Mar 31, 2017 | -$5.31M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.14M | – |
See a number that looks wrong?